These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19227581)

  • 1. C. difficile rates in hospital higher than expected.
    Hosp Health Netw; 2008 Dec; 82(12):47. PubMed ID: 19227581
    [No Abstract]   [Full Text] [Related]  

  • 2. Collateral damage. The rise of resistant C. difficile.
    Taubes G
    Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789
    [No Abstract]   [Full Text] [Related]  

  • 3. Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital.
    Freeman J; Stott J; Baines SD; Fawley WN; Wilcox MH
    J Antimicrob Chemother; 2005 Nov; 56(5):988-9. PubMed ID: 16195254
    [No Abstract]   [Full Text] [Related]  

  • 4. Increase in use of vancomycin for Clostridium difficile infection in US hospitals.
    Pakyz AL; Carroll NV; Harpe SE; Oinonen M; Polk RE
    Infect Control Hosp Epidemiol; 2010 Aug; 31(8):867-8. PubMed ID: 20586649
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
    Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
    N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported Clostridium difficile rates: accurate and targeting the problem?
    Ahmed-Little Y
    J Hosp Infect; 2007 Oct; 67(2):197-8. PubMed ID: 17884249
    [No Abstract]   [Full Text] [Related]  

  • 7. Predominance of Clostridium difficile ribotypes 012, 027 and 046 in a university hospital in Chile, 2012.
    Plaza-Garrido Á; Barra-Carrasco J; Macias JH; Carman R; Fawley WN; Wilcox MH; Hernández-Rocha C; Guzmán-Durán AM; Alvarez-Lobos M; Paredes-Sabja D
    Epidemiol Infect; 2016 Apr; 144(5):976-9. PubMed ID: 26489717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for Clostridium difficile-associated diarrhea in long-term care facilities: what you get is not what you see.
    Mylotte JM
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):760-3. PubMed ID: 18578671
    [No Abstract]   [Full Text] [Related]  

  • 9. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.
    Bourgault AM; Lamothe F; Loo VG; Poirier L;
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3473-5. PubMed ID: 17005836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection in the Republic of Ireland: results of a 1-month national surveillance and ribotyping project, March 2009.
    Burns K; Skally M; Solomon K; Scott L; McDermott S; O'Flanagan D; Fanning S; Kyne L; Fenelon L; Fitzpatrick F
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1085-7. PubMed ID: 20731596
    [No Abstract]   [Full Text] [Related]  

  • 12. C. difficile: a menace in hospitals and homes alike.
    Oriola S
    Nursing; 2006 Aug; 36(8):14-5. PubMed ID: 16888483
    [No Abstract]   [Full Text] [Related]  

  • 13. Implementation of standardised surveillance for Clostridium difficile infections in Australia: initial report from the Victorian Healthcare Associated Infection Surveillance System.
    Bull AL; Worth LJ; Richards MJ
    Intern Med J; 2012 Jun; 42(6):715-8. PubMed ID: 22697155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outbreak of Clostridium difficile-associated disease (CDAD) in a German university hospital.
    Graf K; Cohrs A; Gastmeier P; Kola A; Vonberg RP; Mattner F; Sohr D; Chaberny IF
    Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):543-5. PubMed ID: 18982365
    [No Abstract]   [Full Text] [Related]  

  • 15. Confronting Clostridium difficile in inpatient health care facilities.
    McDonald LC
    Clin Infect Dis; 2007 Nov; 45(10):1274-6. PubMed ID: 17968820
    [No Abstract]   [Full Text] [Related]  

  • 16. Public perception of Clostridium difficile.
    Collins JP; Roberts DM; Evans CF; De'Ath HD; Galland RB
    J Hosp Infect; 2009 May; 72(1):80-1. PubMed ID: 19282054
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of observation units on the rate of hospital-acquired infection.
    Sheahan AD; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2013 Dec; 34(12):1318-20. PubMed ID: 24225619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with outbreak of Clostridium difficile 027].
    Olesen B
    Ugeskr Laeger; 2010 Mar; 172(12):952. PubMed ID: 20334786
    [No Abstract]   [Full Text] [Related]  

  • 19. [An epidemic outbreak of necrotizing enterocolitis due to Clostridium difficile in term newborn infants].
    Pérez-González J; Ventura Faci MP; Samper Villagrasa MP; Gallego Beamonte JA; Ruiz Lázaro PJ; Castillo García FJ
    An Esp Pediatr; 1996 Feb; 44(2):173-5. PubMed ID: 8830582
    [No Abstract]   [Full Text] [Related]  

  • 20. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.
    Archibald LK; Banerjee SN; Jarvis WR
    J Infect Dis; 2004 May; 189(9):1585-9. PubMed ID: 15116293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.